Replies to post #34181 on Ayala Pharmaceuticals Inc (ADXS)

[gajj]

not so big. AT-014 and EU deadlines haven't changed and these are Q4

[abuhafsa]

If they had no product approval and no assurance of success, why did they spend that much money on a 'state of the art' manufacturing facility?